Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katarzyna Puto"'
Publikováno v:
Value in Health. 16:872-890
Objective New therapies have attempted to improve on efficacy outcomes observed with docetaxel in patients with metastatic prostate cancer (MPC) who are hormone-therapy refractory or castration-resistant. In addition to the efficacy, patient-reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af353aef5287fd78f328f237c50bc3ab
https://doi.org/10.1016/j.jval.2013.03.1628
https://doi.org/10.1016/j.jval.2013.03.1628
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 71(7)
Purpose The clinical and economic outcomes associated with using injectable anticoagulants for thromboprophylaxis after cancer-related surgery are evaluated. Methods This retrospective cohort analysis was conducted from an institutional perspective u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abf58677c8a8c2bb1f3db0b77b63ca1
https://pubmed.ncbi.nlm.nih.gov/24644116
https://pubmed.ncbi.nlm.nih.gov/24644116
Autor:
Miriam Giraldez, Katarzyna Puto
Publikováno v:
European Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceca1c7c294a2ac1dfc832e0980e5497
https://doi.org/10.1111/j.1600-0609.2010.01457.x
https://doi.org/10.1111/j.1600-0609.2010.01457.x
Publikováno v:
Journal of Allergy and Clinical Immunology. 135:AB274
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c935ca49cfe536d52eea0a3c4567b5a
https://doi.org/10.1016/j.jaci.2014.12.1837
https://doi.org/10.1016/j.jaci.2014.12.1837
Autor:
Katarzyna Puto, Jody Garey
Publikováno v:
The Annals of pharmacotherapy. 39(4)
OBJECTIVE: To review pemetrexed, a novel multi-targeted antifolate agent. DATA SOURCES: A literature search was conducted (1985–September 2004) using MEDLINE and CANCERLIT. Recent abstracts from the American Society of Clinical Oncology were also i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b02e37c49f7cf1166c1abbb2a20067
https://pubmed.ncbi.nlm.nih.gov/15755794
https://pubmed.ncbi.nlm.nih.gov/15755794
Autor:
Changolkar A; Arun Changolkar, Ph.D., M.B.A., is President and Chief Executive Officer, SOAL Pharmatech Solutions, Inc., Philadelphia, PA; at the time of this study he was Manager, U.S. Health Outcomes, GlaxoSmithKline, Philadelphia. Laura Menditto, M.B.A., M.P.H., is Owner, Laura A. Menditto LLC, Newtown, PA; at the time of this study she was Director, Cardiovascular, Metabolic, and Oncology U.S. Health Outcomes, GlaxoSmithKline. Manan Shah, Pharm.D., Ph.D., is Director, Health Services and Outcomes Research, U.S. Medical, Bristol-Myers Squibb Company, Tampa, FL; at the time of this study he was Director, Health Economics and Outcomes Research, Xcenda, AmerisourceBergen Consulting Services, Palm Harbor, FL. Katarzyna Puto, Pharm.D., M.B.A., BCOP, BCPS, s Associate Director, Global Health Economics and Outcomes Research, Xcenda; at the time of this study she was Assistant Director, Medical Communications, Xcenda. Eileen Farrelly, M.P.H., is Associate Director, Xcenda., Menditto L, Shah M, Puto K, Farrelly E
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2014 Apr 01; Vol. 71 (7), pp. 562-9.